People with schizophrenia tend to hallucinate and “hear voices” that aren’t possible for others to observe. The serious ...

A study reveals why some individuals experience auditory hallucinations, linking it to brain process failures in mental ...

Many researchers believe that schizophrenia can affect a person's ability to smell and how they perceive smells. However, the ...

Popular depictions of schizophrenia often focus on visual hallucinations, but auditory hallucinations are far more common. At ...

Such is the case with newly approved Bristol-Myers Squibb drug Cobenfy. The underlying drug was first studied in Alzheimer’s ...

Doctors sometimes use lithium to treat schizophrenia. However, it is not a primary treatment method and evidence of its ...

Researchers identified that impaired corollary discharge (CD) and noisy efference copy (EC) in schizophrenia disrupt ...

For the first time in nearly 30 years, the U.S. Food and Drug Administration has approved a new drug treating schizophrenia, ...

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...